Milestone Pharmaceuticals Inc (MIST)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	7.39% 3.94	3.669	4.978	3.94	3.963
Operating Income/Loss	5.60% -11.83	-12.53	-20.52	-12.35	-9.616
Income/Loss From Continuing Operations Before Tax	8.05% -11.92	-12.97	-20.76	-12.36	-9.439
Income/Loss From Continuing Operations After Tax	8.05% -11.92	-12.97	-20.76	-12.36	-9.439
Net Income/Loss	8.05% -11.92	-12.97	-20.76	-12.36	-9.439
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Earnings Per Share	40.00% -0.12	-0.20	-0.31	-0.19	-0.14
Diluted Earnings Per Share	40.00% -0.12	-0.20	-0.31	-0.19	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-